Crunching the numbers for ABT... Refresh in a moment for the full analysis.
ABBOTT LABORATORIES (ABT)
Healthcare
Deep Overvalued
healthy
$102.84
Updated: 2026-04-09
64
TradeApes Score
add
Financial Strength
70
Healthy
Operating Trend
55
Mixed
Valuation
65
Healthy
Capital Allocation
55
Mixed
Risk
80
Strong
Fair Value
$7.67
DCF Upside
-92.5%
Sector Rank
#11
of 18
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
High P/E — 25–45×, growth premium already priced in
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.